168 related articles for article (PubMed ID: 32901383)
1. The Multi-Faced Role of PAPP-A in Post-Partum Breast Cancer: IGF-Signaling is Only the Beginning.
Jenkins EC; Brown SO; Germain D
J Mammary Gland Biol Neoplasia; 2020 Sep; 25(3):181-189. PubMed ID: 32901383
[TBL] [Abstract][Full Text] [Related]
2. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract][Full Text] [Related]
3. Collagen and PAPP-A in the Etiology of Postpartum Breast Cancer.
Slocum E; Germain D
Horm Cancer; 2019 Dec; 10(4-6):137-144. PubMed ID: 31631239
[TBL] [Abstract][Full Text] [Related]
4. Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer.
Takabatake Y; Oxvig C; Nagi C; Adelson K; Jaffer S; Schmidt H; Keely PJ; Eliceiri KW; Mandeli J; Germain D
EMBO Mol Med; 2016 Apr; 8(4):388-406. PubMed ID: 26951623
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A.
Laursen LS; Overgaard MT; Søe R; Boldt HB; Sottrup-Jensen L; Giudice LC; Conover CA; Oxvig C
FEBS Lett; 2001 Aug; 504(1-2):36-40. PubMed ID: 11522292
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
[TBL] [Abstract][Full Text] [Related]
7. IGF dependent modulation of IGF binding protein (IGFBP) proteolysis by pregnancy-associated plasma protein-A (PAPP-A): multiple PAPP-A-IGFBP interaction sites.
Gaidamauskas E; Gyrup C; Boldt HB; Schack VR; Overgaard MT; Laursen LS; Oxvig C
Biochim Biophys Acta; 2013 Mar; 1830(3):2701-9. PubMed ID: 23671931
[TBL] [Abstract][Full Text] [Related]
8. Selection of the dominant follicle and insulin-like growth factor (IGF)-binding proteins: evidence that pregnancy-associated plasma protein A contributes to proteolysis of IGF-binding protein 5 in bovine follicular fluid.
Rivera GM; Fortune JE
Endocrinology; 2003 Feb; 144(2):437-46. PubMed ID: 12538602
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation.
Monget P; Mazerbourg S; Delpuech T; Maurel MC; Manière S; Zapf J; Lalmanach G; Oxvig C; Overgaard MT
Biol Reprod; 2003 Jan; 68(1):77-86. PubMed ID: 12493698
[TBL] [Abstract][Full Text] [Related]
10. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
[TBL] [Abstract][Full Text] [Related]
11. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.
Giudice LC; Conover CA; Bale L; Faessen GH; Ilg K; Sun I; Imani B; Suen LF; Irwin JC; Christiansen M; Overgaard MT; Oxvig C
J Clin Endocrinol Metab; 2002 May; 87(5):2359-66. PubMed ID: 11994388
[TBL] [Abstract][Full Text] [Related]
12. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability.
Yan X; Baxter RC; Firth SM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1412-20. PubMed ID: 20103653
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion.
Heitzeneder S; Sotillo E; Shern JF; Sindiri S; Xu P; Jones R; Pollak M; Noer PR; Lorette J; Fazli L; Alag A; Meltzer P; Lau C; Conover CA; Oxvig C; Sorensen PH; Maris JM; Khan J; Mackall CL
J Natl Cancer Inst; 2019 Sep; 111(9):970-982. PubMed ID: 30698726
[TBL] [Abstract][Full Text] [Related]
14. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
Resch ZT; Simari RD; Conover CA
Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
[TBL] [Abstract][Full Text] [Related]
16. PAPP-A and cancer.
Conover CA; Oxvig C
J Mol Endocrinol; 2018 Jul; 61(1):T1-T10. PubMed ID: 29844094
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein-4 and -5 by pregnancy-associated plasma protein-A.
Gyrup C; Oxvig C
Biochemistry; 2007 Feb; 46(7):1972-80. PubMed ID: 17249697
[TBL] [Abstract][Full Text] [Related]
18. A common variant of the pregnancy-associated plasma protein-A (PAPPA) gene encodes a protein with reduced proteolytic activity towards IGF-binding proteins.
Bøtkjær JA; Noer PR; Oxvig C; Yding Andersen C
Sci Rep; 2019 Sep; 9(1):13231. PubMed ID: 31519945
[TBL] [Abstract][Full Text] [Related]
19. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
20. Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis.
Tanaka Y; Kobayashi H; Suzuki M; Hirashima Y; Kanayama N; Terao T
Int J Cancer; 2004 Apr; 109(3):336-47. PubMed ID: 14961570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
